Narnatumab is a human monoclonal antibody directed against RON (recepteur d'origine nantais; macrophage stimulating 1 receptor). Narnatumab has been used in the research of cancer therapy.
BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.